Key growth drivers include major biologics' patent expirations and cost-effectiveness, while European market leads with 45.8% share in 2023.Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars: ...

The launch of the first Biosimilar in retina/ophthalmology space In September of 2021, the FDA approved Byooviz , which references Roche and Novartis’ blockbuster eye drug Lucentis.

JC Scott, CEO and president of The Pharmaceutical Care Management Association, discusses current efforts in increasing biosimilar adoption and pharmacy benefit manager (PBM) reform. Pharmacy ...

Amneal Pharmaceuticals Inc (AMRX) reports robust revenue growth and outlines strategic initiatives for biosimilars and international expansion.

The UK health service has well over a decade’s experience of dealing with biosimilars, but the NHS acknowledges that it has yet to make the most of these drugs. That was certainly one of the ...

Sarfaraz K. Niazi, PhD, shares his latest citizen's petition to the FDA, calling on the agency to waive clinical efficacy ...

A decade since the first biosimilar medicine reached the U.S. market, pharmacy benefit managers are getting serious about these lower-cost versions of biologic drugs. CVS Caremark, OptumRx ...

Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its ...